7/1/2013 7:53:27 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has been added to the Russell 2000 Index effective after the close of market on Friday, June 28, 2013, as part of Russell Investments’ annual index reconstitution. ACADIA also was added to the Russell 3000 and Russell Global Indexes.
Help employers find you! Check out all the jobs and post your resume.
comments powered by